About
Technology
Issues
FAQ
Links
Official Page
An Early Clinical Phase II Evaluation of Paroxetine, a New Potent and Selective 5HT-Uptake Inhibitor in Patients with Depressive Illness
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.